Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2025-12-24 @ 3:00 PM
NCT ID:
NCT02631759
Eligibility Criteria:
Inclusion Criteria:
* Age greater than 18 years with no upper age limit
* Competent adult patient.
* Patient affiliated to the French National Health Insurance.
* Patient with supratentorial spontaneous intracerebral hemorrhage diagnosed by CT or MRI
* Early neurological symptoms less than 24 hours
* NIHSS score on admission between 5 and 25
* Informed consent given by the patient or his legal representative
Exclusion Criteria:
* Inaugural Seizures ( at the onset of symptoms associated with intracerebral hemorrhage )
* Seizures occurring between the inclusion of the patient and the start of the EEG
* Other Intracerebral hemorrhage infratentorial , post-traumatic , related to a vascular malformation or an underlying tumor and secondarily hemorrhagic cerebral infarction
* Current antiepileptic treatment when intracerebral hemorrhage , or a history of epilepsy
* Modified Rankin Scale before intracerebral hemorrhage \> 1 (indicating a preexisting disability)
* Serious illness which can affect the prognosis within 3 months
* Severe renal impairment ( creatinine clearance \<30 ml / min)
* Pregnancy, lactation
* Known hypersensitivity to levetiracetam or other pyrrolidone derivatives , or any of the excipients.
* Untreated severe depression , psychotic disorders
* Lactose Intolerance
* Patient under measuring socio- legal protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02631759
Study Brief:
Protocol Section:
NCT02631759